MONTE ROSA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.16 USD | +4.26% |
|
-20.00% | -26.37% |
| May. 16 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
| May. 16 | Monte Rosa Therapeutics Prices $100 Million Public Offering | MT |
Chart calendar Monte Rosa Therapeutics, Inc.
3e65aa7d41dd.i7hmXnQxgLlrVPXVvNmobGUrgKLyX5RyQjRAAkBb8pE.5-oHbBFu6PIIEZO_jezRLVZjt_CaD_E5OwwNdjkBg6G66EsxPH3k2CYBuA~308914a47fc4d081fa542b3cdafbc3eb
Upcoming events on Monte Rosa Therapeutics, Inc.
Past events on Monte Rosa Therapeutics, Inc.
| 2024-05-21 12:30 pm | Digestive Disease Week Conference |
| 2024-05-09 07:00 am | Q1 2024 Earnings Release |
| 2024-03-14 07:00 am | Q4 2023 Earnings Release |
| 2024-03-06 09:10 am | TD Cowen Health Care Conference |
| 2024-02-07 01:30 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 2024-01-10 06:00 pm | JPMorgan Healthcare Conference |
| 2023-11-28 03:30 pm | Piper Sandler Healthcare Conference |
| 2023-11-13 | Jefferies London Healthcare Conference |
| 2023-11-12 12:00 pm | American College of Rheumatology Conference - Abstract No: #0082 |
| 2023-11-09 07:00 am | Q3 2023 Earnings Release |
| 2023-11-03 01:00 pm | TD Cowen Fall Oncology Innovation Summit - Fireside Chat |
| 2023-10-17 08:00 am | MRT-2359 Phase 1/2 Trial Results Call |
| 2023-08-10 07:15 am | Q2 2023 Earnings Release |
| 2023-06-14 08:30 am | Annual General Meeting |
| 2023-06-05 01:00 pm | BIO International Convention |
| 2023-05-11 07:30 am | Q1 2023 Earnings Release |
| 2023-04-17 02:30 pm | American Association for Cancer Research Meeting - Abstract No.: 3449 |
| 2023-04-17 10:15 am | American Association for Cancer Research Meeting - New Drugs on the Horizon - Discovery of MRT-2359 |
| 2023-03-16 07:31 am | Q4 2022 Earnings Release |
| 2023-03-07 10:30 am | Cowen Health Care Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 15,1 - | 6,80 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -70,8 -69,0 -2.54% | -109 -104 -3.99% | -137 -93,4 -46.8% | -143 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -72,9 -72,0 -1.28% | -112 -109 -2.95% | -143 -131 -9.04% | -147 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -74,0 -73,4 -0.76% | -109 -108 -0.92% | -135 -123 -9.41% | -139 |
|
Net income Million USD | Released Forecast Spread | -35,9 | -74,0 -73,7 -0.41% | -109 -108 -0.44% | -135 -124 -9.53% | -139 |
|
EPS USD | Released Forecast Spread | -6,70 | -2,96 -2,61 -13.45% | -2,30 -2,28 -0.8% | -2,63 -2,42 -8.79% | -2,12 |
| Announcement Date | 04/06/21 | 29/03/22 | 16/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 15,1 - | 1,06 1,40 -24% | 1,35 | 1,35 | 1,78 | 1,80 | 1,80 |
|
EBITDA Million USD | Released Forecast Spread | -31,4 -30,0 -4.66% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -24,3 -25,3 3.94% | -27,2 -21,8 -24.72% | -28,4 -27,7 -2.29% | -32,5 -30,2 -7.47% | -34,3 -33,3 -2.8% | -37,2 -34,7 -7.3% | -37,0 -37,7 1.92% | -34,9 -23,1 -51.22% | -36,0 -35,6 -1.21% | -36,2 | -38,0 | -37,6 | -44,2 | -46,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,9 -25,7 6.87% | -26,5 -21,8 -21.36% | -27,3 -28,0 2.4% | -30,8 -29,6 -3.9% | -32,0 -32,9 2.73% | -35,0 -34,2 -2.41% | -34,7 -36,6 5.2% | -33,3 -21,6 -54.02% | -31,9 -34,2 6.77% | -34,3 | -36,2 | -36,2 | -43,2 | -45,4 |
|
Net income Million USD | Released Forecast Spread | -23,9 -25,7 6.73% | -26,5 -22,6 -17.15% | -27,3 -28,2 3.2% | -30,8 -30,2 -1.82% | -32,0 -33,3 3.74% | -35,2 -34,5 -1.85% | -34,9 -36,9 5.47% | -33,3 -21,6 -53.92% | -32,0 -34,2 6.53% | -34,3 | -36,2 | -36,2 | -43,2 | -45,4 |
|
EPS USD | Released Forecast Spread | -0,51 -0,54 5.57% | -0,57 -0,48 -18.42% | -0,58 -0,60 3.56% | -0,63 -0,62 -0.92% | -0,65 -0,68 4.5% | -0,71 -0,70 -1.89% | -0,70 -0,74 6.02% | -0,58 -0,39 -46.94% | -0,53 -0,57 7.53% | -0,55 | -0,55 | -0,52 | -0,54 | -0,51 |
| Announcement Date | 11/05/22 | 11/08/22 | 10/11/22 | 16/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 14/03/24 | 09/05/24 | - | - | - | - | - |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Monte Rosa Therapeutics, Inc.
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GLUE Stock
- Calendar Monte Rosa Therapeutics, Inc.
